Mimedx (MDXG) Net Margin Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 49,253.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 506.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -569.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,218.00 |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -1,335.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,335.00 |
| Dec 31, 2024 | 1,076.00 |
| Sep 30, 2024 | 1,558.00 |
| Jun 30, 2024 | 2,501.00 |
| Mar 31, 2024 | 2,712.00 |
| Dec 31, 2023 | 7,797.00 |
| Sep 30, 2023 | 8,949.00 |
| Jun 30, 2023 | 2,504.00 |
| Mar 31, 2023 | 275.00 |
| Dec 31, 2022 | 2,072.00 |
| Sep 30, 2022 | -2,885.00 |
| Jun 30, 2022 | 684.00 |
| Mar 31, 2022 | -56.00 |
| Dec 31, 2021 | 3,637.00 |
| Sep 30, 2021 | -600.00 |
| Jun 30, 2021 | -670.00 |
| Mar 31, 2021 | -2,191.00 |
| Dec 31, 2020 | -3,701.00 |
| Sep 30, 2020 | -9,700.00 |
| Jun 30, 2020 | -2,334.00 |
| Mar 31, 2020 | -1,618.00 |
| Dec 31, 2019 | -105.00 |
| Sep 30, 2019 | 878.00 |
| Jun 30, 2019 | -2,896.00 |
| Mar 31, 2019 | -2,219.00 |
| Dec 31, 2018 | -6,493.00 |
| Sep 30, 2018 | -1,357.00 |
| Jun 30, 2018 | -1,000.00 |
| Mar 31, 2018 | -454.00 |
| Dec 31, 2017 | 98.00 |
| Sep 30, 2017 | 512.00 |
| Jun 30, 2017 | 908.00 |
| Mar 31, 2017 | 1,309.00 |
| Dec 31, 2016 | -80.00 |
| Sep 30, 2016 | 706.00 |
| Jun 30, 2016 | 905.00 |
| Mar 31, 2016 | 1,627.00 |
| Dec 31, 2015 | 4,109.00 |
| Sep 30, 2015 | 6,641.00 |
| Jun 30, 2015 | 2,712.00 |
| Mar 31, 2015 | 3,954.00 |
| Dec 31, 2014 | 10,747.00 |
| Sep 30, 2014 | 9,309.00 |
| Jun 30, 2014 | 12,823.00 |
| Mar 31, 2014 | 31,609.00 |